Extracellular Vesicles as Novel Diagnostic and Therapeutic Agents for Non-Melanoma Skin Cancer: A Systematic Review
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25052617 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Konstantinos Seretis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, Medical School, University of Ioannina, 45100 Ioannina, Greece. Hauptthemen laut MEDLINE: Extracellular Vesicles, Exosomes, Skin Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Standard non-melanoma skin cancer (NMSC) treatment involves surgery, recently combined with chemotherapy or immunotherapy in cases of advanced tumors. EVs, including exosomes, are integral to carcinogenesis, and are found in NMSC releasing mediators impacting tumor progression. Nevertheless, the precise intercellular signaling role of NMSC-derived EVs remains unclear. This review aims to elucidate their potential role in NMSC diagnosis and treatment. This systematic review encompassed literature searches in electronic databases from inception to September 2023, based on certain inclusion and exclusion criteria, addressing NMSC-derived EVs, their molecular cargo, and their implications in the diagnosis, prognosis, and treatment of NMSC. Key components were identified. Extracellular vesicle (EV) proteins and RNA have emerged as diagnostic biomarkers in EV-based liquid biopsy. Circular RNA CYP24A1, known for its molecular stability, holds promise as a diagnostic biomarker. Long noncoding RNAs (lincRNA-PICSAR) and Desmoglein 2 (DSg2) are linked to drug resistance, serving as prognostic biomarkers. EV mediators are being actively investigated for their potential role as drug delivery agents. In conclusion, this systematic review showed that NMSC-derived EVs display promise as therapeutic targets and diagnostic biomarkers. Further research is imperative to fully comprehend EV mechanisms and explore their potential in cancer diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic Surgery, Medical School, University of Ioannina, 45100 Ioannina, Greece.
ORCID-Profile: Konstantinos Seretis
Zitieren
APA
Seretis, K., Boptsi, E., & Boptsi, A. (2024). Extracellular Vesicles as Novel Diagnostic and Therapeutic Agents for Non-Melanoma Skin Cancer: A Systematic Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25052617
Vancouver
Seretis K, Boptsi E, Boptsi A. Extracellular Vesicles as Novel Diagnostic and Therapeutic Agents for Non-Melanoma Skin Cancer: A Systematic Review. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25052617
BibTeX
@article{Seretis2024,
author = {Seretis, Konstantinos and Boptsi, Eleni and Boptsi, Anastasia},
title = {Extracellular Vesicles as Novel Diagnostic and Therapeutic Agents for Non-Melanoma Skin Cancer: A Systematic Review},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25052617}
}
EUVIMED